Established in 1921 and now a member of the Teva Group (through Teva's acquisition of Barr in 2008), PLIVA develops and manufactures finished dosage forms and active pharmaceutical ingredients on its sites in Zagreb and Savski Marof. PLIVA has state-of-the-art development and production capacities and markets a broad range of high-quality generics offering superior therapeutic solutions in a number of markets in Europe and worldwide. PLIVA's product portfolio includes oral and injectable dosage forms, creams/ointments, over-the-counter products and active pharmaceutical ingredients. Prescription medicines are sold to wholesalers and hospitals, while over-the-counter products may be found in pharmacies. PLIVA bases its operations on competitive production, continuous customer care and cooperation with all healthcare system segments in both Croatia and throughout the region. The integration with Teva has additionally strengthened PLIVA's leading position in Croatia and in key international markets where PLIVA can offer a broad portfolio of high quality generic medicines.

Company was acquired by Barr Pharmaceuticals Inc.

Acquired Companies: Odyssey Pharmaceuticals